What is Known About the Association of Antinuclear Antibodies Development During Treatment with TNF Blockers?

Autor Lebwohl, Mark
Vydáno 2008

A Safety Assessment of Topical Calcineurin Inhibitors in the Treatment of Atopic Dermatitis

Autor Lebwohl, Mark, Gower, Tara
Vydáno 2006

Comprehensive Literature Review of Obstetric Outcomes and Fetal Risk during Pregnancy with Pseudoxanthoma Elasticum

Autor Lee, Raphael, Lebwohl, Mark
Vydáno v J Clin Med (2021)

Psoriasis: Overview and Diagnosis

Autor Kimmel, Grace W., Lebwohl, Mark
Vydáno v Evidence-Based Psoriasis (2018)

Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis

Autor Koutruba, Nora, Emer, Jason, Lebwohl, Mark
Vydáno 2010

Impact of Baseline Disease Severity Over 26 and 52 Weeks of Treatment with Calcitriol Ointment 3µg/g in Patients with Mild-to-moderate Plaque Psoriasis

Autor Lebwohl, Mark, Preston, Norman, Gottschalk, Ronald W.
Vydáno 2012

IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies

Autor Blauvelt, Andrew, Lebwohl, Mark G, Bissonnette, Robert
Vydáno v J Invest Dermatol (2015)

Efficacy and safety of ustekinumab in adolescents

Autor Kellen, Roselyn, Silverberg, Nanette B, Lebwohl, Mark
Vydáno v Pediatric Health Med Ther (2016)

Reply to research letter

Autor Rivera-Oyola, Ryan, Koschitzky, Merav, Lebwohl, Mark
Vydáno v J Am Acad Dermatol (2020)

The Psoriasis Decision Tree

Autor Monks, George, Rivera-Oyola, Ryan, Lebwohl, Mark
Vydáno v J Clin Aesthet Dermatol (2021)

Should biologics for psoriasis be interrupted in the era of COVID-19?

Autor Lebwohl, Mark, Rivera-Oyola, Ryan, Murrell, Dedee F.
Vydáno v J Am Acad Dermatol (2020)

Reply to: “Biologics for psoriasis during COVID-19 outbreak”

Autor Murrell, Dedee F., Rivera-Oyola, Ryan, Lebwohl, Mark
Vydáno v J Am Acad Dermatol (2020)

Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”

Autor Lebwohl, Mark, Rivera-Oyola, Ryan, Murrell, Dedee F.
Vydáno v J Am Acad Dermatol (2020)

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Ammonium Lactate Lotion 12% and Halobetasol Propionate Ointment 0.05% in the Treatment a...

Autor Emer, Jason J., Frankel, Amylynne, Sohn, Andrew, Lebwohl, Mark
Vydáno 2011

Pseudoxanthoma elasticum: Mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter

Autor Ringpfeil, Franziska, Lebwohl, Mark G., Christiano, Angela M., Uitto, Jouni
Vydáno 2000

Infrared Camera Evaluation of the Cooling Effect of Triamcinolone Acetonide Aerosol

Autor Linkner, Rita V., Sohn, Andrew, Goldenberg, Kristin A, Lebwohl, Mark
Vydáno 2013

Relationship between severity of the local skin reactions and the rate of local skin reaction resolution in patients treated with ingenol mebutate gel

Autor Jim On, Shelbi C, Knudsen, Kim Mark, Skov, Torsten, Lebwohl, Mark
Vydáno v Clin Cosmet Investig Dermatol (2016)

“COVID arm”: A reaction to the Moderna vaccine

Autor Wei, Nancy, Fishman, Mary, Wattenberg, Debra, Gordon, Marsha, Lebwohl, Mark
Vydáno v JAAD Case Rep (2021)

US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic...

Autor Lebwohl, Mark G., Kavanaugh, Arthur, Armstrong, April W., Van Voorhees, Abby S.
Vydáno v Am J Clin Dermatol (2015)

Malignancy Rates in Brodalumab Clinical Studies for Psoriasis

Autor Gottlieb, Alice, Lebwohl, Mark, Liu, Clive, Israel, Robert J., Jacobson, Abby
Vydáno v Am J Clin Dermatol (2020)